Validation and Implementation of Clinical Laboratory Improvements Act-Compliant Whole-Genome Sequencing in the Public Health Microbiology Laboratory

Abstract

Public health microbiology laboratories (PHLs) are on the cusp of unprecedented improvements in pathogen identification, antibiotic resistance detection, and outbreak investigation by using whole-genome sequencing (WGS). However, considerable challenges remain due to the lack of common standards. Here, we describe the validation of WGS on the Illumina platform for routine use in PHLs according to Clinical Laboratory Improvements Act (CLIA) guidelines for laboratory-developed tests (LDTs). We developed a validation panel comprising 10 Enterobacteriaceae isolates, 5 Gram-positive cocci, 5 Gram-negative nonfermenting species, 9 Mycobacterium tuberculosis isolates, and 5 miscellaneous bacteria. The genome coverage range was 15.71× to 216.4× (average, 79.72×; median, 71.55×); the limit of detection (LOD) for single nucleotide polymorphisms (SNPs) was 60×. The accuracy, reproducibility, and repeatability of base calling were >99.9%. The accuracy of phylogenetic analysis was 100%. The specificity and sensitivity inferred from multilocus sequence typing (MLST) and genome-wide SNP-based phylogenetic assays were 100%. The following objectives were accomplished: (i) the establishment of the performance specifications for WGS applications in PHLs according to CLIA guidelines, (ii) the development of quality assurance and quality control measures, (iii) the development of a reporting format for end users with or without WGS expertise, (iv) the availability of a validation set of microorganisms, and (v) the creation of a modular template for the validation of WGS processes in PHLs. The validation panel, sequencing analytics, and raw sequences could facilitate multilaboratory comparisons of WGS data. Additionally, the WGS performance specifications and modular template are adaptable for the validation of other platforms and reagent kits.

VAPiD: a lightweight cross platform viral annotation pipeline and identification tool to facilitate virus genome submissions to NCBI GenBank

“…State and federal public health laboratories have built capacity such that they now sequence more than 6,000 influenza virus genomes and more than 5,000 enteropathogenic bacterial genomes each year [11]. Major efforts in rationalizing workflows, from nucleic acid extraction to data deposition and analysis, have enabled these rapid growths in throughput [12–14]. These tools allow public health and research laboratories to focus on the epidemiological or scientific insight gained from sequencing rather than rote protocols for data deposition.…”

Rapid and accurate SNP genotyping of clonal bacterial pathogens with BioHansel

“…Further gains were observed increasing sequence coverage levels with approximately a fourteen-fold reduction in compute time at 50X coverage. With a recommended minimum genome coverage of 60X to detect all the SNPs in a bacterial genome (Kozyreva et al, 2017), this represents a substantial time savings.…”

The global phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunistStenotrophomonas maltophilia

“…To validate the scheme, a collection of repeatedly sequenced ATCC strains 52 as well as sequence reads sets from published work 41 were analyzed with the wgMLST scheme in BioNumerics (v7.6.3). For the technical replicates (same sequence read set analysed multiple times), the number of consensus allele calls and allelic profiles were identical.…”